Skip to NavigationSkip to content

Pfizer’s Kristin Peck gains business development role

Published on: 01/03/10

Kristin Peck has been appointed senior vice president, worldwide business development, strategy and innovation at Pfizer.

She succeeds William Ringo in the role, which will see her assume responsibility for business development activities and ensuring their alignment with Pfizer’s strategic objectives.

“Kristin has already been playing a leadership role in strategic planning for the company. Her knowledge, expertise and energy make her an excellent choice for this leadership position,” Pfizer’s chairman and chief executive Jeff Kindler said.

“Kristin will work closely with me and other Pfizer executives to advance our business development goals effectively and with an efficient use of our owners’ capital.”

Peck joined Pfizer in 2004 in the company’s strategic planning organisation. Prior to Pfizer, she was a principal with the Boston Consulting Group, focusing on strategy and merger-related issues in the pharmaceutical and financial services industries, and worked in real estate financial services and private equity at Prudential and The O’Connor Group.

At Pfizer she most recently played a leadership role in the integration of Wyeth’s global operations, while serving as senior vice president of worldwide strategy and innovation.

Meanwhile Ringo, her predecessor in her new role, will retire from the company with effect from 30 April.

“Bill has accomplished a great deal in positioning Pfizer for future success,” said Kindler.

“He has helped diversify Pfizer’s portfolio through our acquisition of Wyeth; worked to create a new world-leading, specialist HIV company, called ViiV Healthcare, through our joint venture with GlaxoSmithKline; and played a leadership role in securing rights to novel, promising compounds.”

“He also connected the company more closely with the expanding opportunities in biotechnology,” Kindler added.

Ringo joined Pfizer in April 2008, after retiring from Eli Lilly & Company, where over his 28-year tenure he held a number of senior positions.

"It has been a real pleasure to be part of Pfizer's Executive Leadership Team,” Ringo said. “Based on my four decades of experience in the industry, I truly believe the future for Pfizer is extremely bright, as our colleagues provide quality medicines to patients around the world,” he added.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches